BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10884987)

  • 21. The concept of perihilar cholangiocarcinoma is valid.
    Ebata T; Kamiya J; Nishio H; Nagasaka T; Nimura Y; Nagino M
    Br J Surg; 2009 Aug; 96(8):926-34. PubMed ID: 19591162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Kinoshita H
    Hepatogastroenterology; 2002; 49(44):326-9. PubMed ID: 11995443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
    Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
    Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma.
    Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Yamazaki O; Shuto T; Tanaka H; Kinoshita H
    Hepatogastroenterology; 2003; 50(52):1069-72. PubMed ID: 12845984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan.
    Nagakawa T; Kayahara M; Ikeda S; Futakawa S; Kakita A; Kawarada H; Matsuno M; Takada T; Takasaki K; Tanimura H; Tashiro S; Yamaoka Y
    J Hepatobiliary Pancreat Surg; 2002; 9(5):569-75. PubMed ID: 12541042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].
    Ramacciato G; Di Benedetto F; Cautero N; Masetti M; Mercantini P; Corigliano N; Nigri G; Lauro A; Ercolani G; Del Gaudio M; De Ruvo N; Pinna AD
    Chir Ital; 2004; 56(6):749-59. PubMed ID: 15771027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Segmental liver resections for hilar cholangiocarcinoma.
    Nagino M; Nimura Y; Kamiya J; Kanai M; Uesaka K; Hayakawa N; Yamamoto H; Kondo S; Nishio H
    Hepatogastroenterology; 1998; 45(19):7-13. PubMed ID: 9496478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical indication and significance of portal vein resection in biliary and pancreatic cancer.
    Tashiro S; Uchino R; Hiraoka T; Tsuji T; Kawamoto S; Saitoh N; Yamasaki K; Miyauchi Y
    Surgery; 1991 Apr; 109(4):481-7. PubMed ID: 1848949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging.
    Lin G; Toh CH; Wu RC; Ko SF; Ng SH; Chou WC; Tseng JH
    Int J Clin Pract; 2008 Aug; 62(8):1199-205. PubMed ID: 17537192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years.
    Sano T; Shimada K; Sakamoto Y; Esaki M; Kosuge T
    J Hepatobiliary Pancreat Surg; 2007; 14(5):455-62. PubMed ID: 17909713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical treatment of hilar carcinoma of the bile duct.
    Mizumoto R; Kawarada Y; Suzuki H
    Surg Gynecol Obstet; 1986 Feb; 162(2):153-8. PubMed ID: 3945893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatopancreatoduodenectomy: its suitability for bile duct cancer versus gallbladder cancer.
    Kaneoka Y; Yamaguchi A; Isogai M
    J Hepatobiliary Pancreat Surg; 2007; 14(2):142-8. PubMed ID: 17384904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
    Aishima S; Kuroda Y; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procedure of extended hilar bile duct resection and its application for hilar cholangiocarcinoma.
    Shimada H; Endo I; Fujii Y; Kunihiro O; Tanaka K; Misuta K; Togo S
    Hepatogastroenterology; 2002; 49(44):300-5. PubMed ID: 11995438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis.
    Asakura H; Ohtsuka M; Ito H; Kimura F; Ambiru S; Shimizu H; Togawa A; Yoshidome H; Kato A; Miyazaki M
    Hepatogastroenterology; 2005; 52(63):722-4. PubMed ID: 15966191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hilar cholangiocarcinoma].
    Miyazaki M; Ito H; Kimura F; Shimizu H; Togawa A; Ohtsuka M; Yoshidome H; Kato A; Yoshitomi H; Sawada S; Ambiru S
    Nihon Geka Gakkai Zasshi; 2005 Apr; 106(4):291-6. PubMed ID: 15859140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The experiences of hilar skeletonization for the treatment of locally advanced proximal bile duct cancer.
    Kim MW; Kim WH; Wang HJ; Chung JB; Chun M
    Hepatogastroenterology; 2001; 48(41):1298-301. PubMed ID: 11677950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.
    Li SQ; Liang LJ; Hua YP; Peng BG; He Q; Lu MD; Chen D
    Chin Med J (Engl); 2009 Oct; 122(19):2286-91. PubMed ID: 20079127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases.
    Uenishi T; Kubo S; Yamazaki O; Yamada T; Sasaki Y; Nagano H; Monden M
    J Hepatobiliary Pancreat Surg; 2008; 15(4):417-22. PubMed ID: 18670844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.